This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Hiroshi Yuita: Innovator in Pharmaceutical Chemistry
Introduction
Hiroshi Yuita is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Hiroshi Yuita holds a patent for an imidazole derivative. This invention aims to provide a novel compound or an isotope thereof, or a pharmaceutically acceptable salt thereof, that possesses S1P lyase inhibitory capacity. The compound is designed to induce a decrease in the number of lymphocytes, making it a valuable addition to pharmaceutical compositions containing these active ingredients.
Career Highlights
Yuita is associated with Daiichi Sankyo Company, Limited, where he applies his expertise in drug development. His work has been instrumental in advancing the company's research initiatives and enhancing its product offerings. With a focus on innovative pharmaceutical solutions, he continues to contribute to the field.
Collaborations
Hiroshi Yuita collaborates with esteemed colleagues, including Nobuo Machinaga and Fumihito Muro. These partnerships foster a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Hiroshi Yuita's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in healthcare. His patent for an imidazole derivative highlights his commitment to developing effective therapeutic solutions. Through his work at Daiichi Sankyo Company, Limited, he continues to shape the future of medicine.